Skip to main content
OpenTrials
Completed

NCT Number: NCT07828314

Patient Priorities in the Management of Early Oesophageal Cancer: A Discrete Choice Study

Understanding patient priorities is important to providing thorough, individualised care in oesophageal cancer. We aim to use questionnaires to explore what is important to patients when considering radical surgery for oesophageal cancer, and to analyse how patients interpret the risk explained to them during the consent process

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Portsmouth Hospitals University NHS Trust

Portsmouth, Hampshire, PO6 3LY, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Under care of local MDT for monitoring/surveillance/treatment of Barretts/dysplasia/oesophageal cancer
  • able to communicate in English Language

Exclusion criteria

  • Unable or unwilling to give informed consent

Treatment and study plan

Semi-structured interview

Behavioral

Interviews will be facilitated by the research team. The sessions will be designed to follow the consolidated criteria for reporting qualitative research (COREQ) (12). The Questionnaire on Distress in Cancer Patients and The Cancer Worry Scale (both validated patient surveys) were also used to help design the script for the interview. The full interview script can be found in a separate document entitled "Patient priorities in Oesophageal Cancer".

Discrete Choice Experiment

Behavioral

Participants will be asked to imagine the following scenario; "You have undergone endoscopic resection for an early oesophageal cancer. All your cancer has been removed, but the histology from your endoscopic resection shows you are at an increased risk of recurrence. This risk could be reduced by undergoing a radical oesophagectomy. The following options are presented to you;"

  • Questionnaire will involve choosing between 2 treatments options; Active surveillance or radical surgery.
  • 5 attributes will be assigned to each treatment option. Examples of possible attributes; 5-year survival (this pertains to risk of nodal/distant metastases) Risk of mortality from surgery Short-term HRQoL Long-term HRQoL Frequency of invasive tests
  • Each attribute will have 3 levels
  • It would not be possible to expose patients to all choice sets (>200). Software will be used to design 20 choice sets that will make up the questionnaire.

Primary outcomes

  1. Patient priorities

    Time frame: 6 months

    Interview responses and responses from discrete choice experiment.

Sponsors and collaborators

Lead sponsor

Portsmouth Hospitals NHS Trust

Other Gov

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 18, 2026
Registry last updated
Sep 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.